New scoring tool aims to predict Drug-Related ER returns
NCT ID NCT04181775
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a risk prediction tool called ADE-RED, designed to identify emergency department patients at high risk for drug-related hospital readmissions. Researchers followed 471 patients to see if using the tool could reduce repeat visits. The goal is to improve discharge planning and prevent future drug-related emergencies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If the tool works, it could help emergency doctors identify patients who need extra medication review before discharge, potentially reducing drug-related hospital returns.
- What could go wrong
- This is a completed study testing a prediction tool, not a treatment. The tool may not reduce readmissions as hoped, and results may not apply to all hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE DRUG EVENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study tracks COVID-19 vaccine side effects in kids ages 5 to 16
- Massive study to uncover hidden mental toll of cancer
- Gene study aims to predict chemo side effects in kids with leukemia
- EHR nudge study to curb dangerous drug mixes in seniors pulled before start
- New sedative could keep ICU patients calmer on ventilators
- Could your own immune cells beat advanced melanoma?